Skip to content

Clinical study of juzentaihoto on Late Onset Hypogonadism

A Clinical study of juzentaihoto on Late Onset Hypogonadism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1061200053
Enrollment
20
Registered
2021-02-08
Start date
2021-05-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Late onset hypogonadism

Interventions

Tsumura Juzentaihoto 2.5 g given aftermeals or between meals 3 times per day for 56 days. The dosage and the number of administration of the drug are modified according to the age, body weight, and sy

Sponsors

Ueda Keigo
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Male between the age of 30 and 74 2. Blood free testosterone level is below normal range and diagnosed as late onset hypogonadism 3. Not having past history of gonadal failure 4. Androgen replacement therapy (ART) is not applicable 5. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Past history of adverse event by the drug used in this study 2. Judged by researchers to be inappropriate as a study subject

Design outcomes

Primary

MeasureTime frame
1. Changes in blood free testosterone level

Secondary

MeasureTime frame
1. Changes in Aging males' symptom (AMS) score, Self-rating Depression Scale (SDS), F scle (FSSG) after 8 weeks of intervention. 2. Changes in Kampo medical conditions score after 8 weeks of intervention. 3. Adverse event caused by Tsumura Juzentaihoto.

Contacts

Public ContactKeigo Ueda

Okayama University Academic Field of Medicine, Dentistry and Pharmaceutical Sciences

philopotchy@live.jp+81-86-235-7342

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026